Found in translation

With almost $1 billion in new venture funds in the last year and a half aimed at academic research, Europe is showing signs of a dedicated effort among investors and universities alike to tap into the translational science stemming from its research organizations.

The bulk of that sum comes from U.K.-based funds, reflecting a recent push by the U.K. government, investors and academics to advance the country's biotech ecosystem by promoting the commercialization of its breakthrough research (see Cover Story). ...